Claris Law Legal Blogging Community

Name:

E-mail:

Phone Number:

Zip Code:

Your Question:

Editor: Jamie Sheller
Profession: Trasylol Attorney

Category: About Trasylol

Trasylol was recalled in November after reports that it increases the risk of death by 50 percent over drugs in the same class. It is used to stop bleeding during open heart surgery. The active component in Trasylol is Aprotinin. Aprotinin is also found in the drug Trasynin. It was also recalled by Bayer.

The CHMP recommendation follows the suspension of the aprotinin-containing medicines for systemic use in Germany on 5 November 2007. The German National Competent Authority based its decision on newly available interim results from the BART clinical trial, showing increased mortality for patients receiving aprotinin. The study was stopped and the German manufacturer, Bayer, subsequently decided to suspend the worldwide marketing of its aprotinin-containing medicinal products, Trasylol and Trasynin.

Trasylol and Trasynin may be responsible for countless injuries around the world. The drugs are linked to heart attacks, stroke, and kidney failure leading to death. Further research is being done to test the safety of these drugs.